Spindle cell tumours of the female genital tract

Olaejirinde O. Olaofe; Chigozie C. Okongwu

doi:10.18203/2320-1770.ijrcog20232927

Authors

Olaejirinde O. Olaofe Department of Morbid Anatomy and Forensic Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria
Chigozie C. Okongwu Department of Morbid Anatomy and Forensic Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20232927

Keywords:

Spindle cell, Leiomyoma, Leiomyosarcoma, Mullerian

Abstract

Background: Our aim is to describe the clinicopathology features of spindle cell tumors of the female genital tract seen in our hospital and to compare the findings with what is seen in other parts of the world.

Methods: We conducted a cross-sectional study of all spindle cell tumors diagnosed in the department of Morbid Anatomy and Forensic medicine of Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria from January 1, 2017, to December 31, 2022.

Results: Leiomyoma was the most common spindle cell tumour seen. Only 570 cases met the inclusion criteria. Only one nodule was removed in 130 cases (22%) while greater than one nodule was excised in 432 cases (75.8%). The mean age of patients was 40.77 years while the age range was 19-79 years. About three-quarters of leiomyomas are removed in the age-group 31-50. There was no correlation between the number of nodules removed and the age of the patient. The next second most common spindle cell tumor seen was malignant mixed mullerian tumour. Eleven cases were seen in the study period, The average age was 57.7 years. The age range of cases was 27-72 years.

Conclusions: Our study supports the general observation that leiomyomas commonly cause symptoms in the reproductive age group and that most patients with leiomyoma frequently have more than one nodule. Our study further reinforces the widely established knowledge that MMMT is found in older post-menopausal women and can occasionally be seen in younger pre-menopausal women.

Metrics

Metrics Loading ...

References

Harmon QE, Actkins KV, Baird DD. Fibroid Prevalence-Still So Much to Learn. JAMA. 2023;6(5): e2312682.

Millien C, Manzi A, Katz AM, Gilbert H, Smith Fawzi MC, Farmer PE, et al. Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study. Int J Equity Health. 2021;20(1):1.

Song S, Park S, Song BM, Lee JE, Cha C, Park HY. Risk of uterine leiomyomata with menstrual and reproductive factors in premenopausal women: Korea nurses’ health study. BMC Womens Health. 2023; 23(1):305.

Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-12.

Katon JG, Bossick A, Carey C, Christy A, Doll K, Gatsby E, et al. Racial Disparities in Uterine Fibroid Treatment Among Veterans Using VA Health Care. Women Health Issues. 2023;33(4):405-13.

Lou Z, Huang Y, Li S, Luo Z, Li C, Chu K, et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC. 2023;23(1):916.

Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3-11.

Idowu BM, Ibitoye BO. Doppler sonography of perifibroid and intrafibroid arteries of uterine leiomyomas. Obstet Gynecol Sci. 2018;61(3):395-403.

Morhason-Bello IO, Adebamowo CA. Epidemiology of uterine fibroid in black African women: a systematic scoping review. BMJ Open. 2022;12(8):e052053.

Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015; 21(5):593-615.

Moravek MB, Yin P, Ono M, Coon V, Dyson MT, Navarro A, et al. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. Hum Reprod Update. 2015;21(1):1-12.

Moro E, Degli Esposti E, Borghese G, Manzara F, Zanello M, Raimondo D, et al. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature. Medicina (Kaunas). 2019; 55(9):549.

Stewart EA, Nowak RA. Uterine Fibroids: Hiding in Plain Sight. Physiology. 2022;37(1):16-27.

Andres M de P, Borrelli GM, Abrão MS. Advances on minimally invasive approach for benign total hysterectomy: a systematic review. Physiol Res. 2017; 6:1295.

Wang QM, Zhao Y, Ma Y, Yao LT, Han X. One case report of giant atypical leiomyoma of the ovary. Medicine. 2018;97(40):e12526.

Tomas D, Leniček T, Tučkar N, Puljiz Z, Ledinsky M, Krušlin B. Primary ovarian leiomyoma associated with endometriotic cyst presenting with symptoms of acute appendicitis: a case report. Diagn Pathol. 2009;4:25.

Shrestha S, Homagain S, Kandel S, Jha P, Gurung G. Bilateral ovarian edema with unilateral ovarian leiomyoma and double inferior vena cava: a case report. J Med Case Rep. 2020;14(1):97.

Kitamura Y, Ito F, Kokabu T, Mori T, Kusuki I, Kitawaki J. Primary Ovarian Leiomyoma Associated with Multiple Uterine Leiomyomas. Gynecol Minim Invasive Ther. 2021;10(1):50-2.

Cheng B, Wang R, Fu Y, Fu X. Leiomyoma of the fallopian tube found during laparoscopic myomectomy: A case report and review of the literature. Front Surg. 2023;10:997338.

Sikora-Szczęśniak DL. Leiomyoma and leiomyoma cellulare of the fallopian tube: review of the literature and case reports. Prz Menopauzalny. 2016;15(3):143-7.

Sun D, Yang P, Liu Y, Yu G. Fallopian tube lipoleiomyoma with degeneration: a case report and literature review. Int J Clin Exp Pathol. 2020;13(8): 2163-8.

Shah M, Saha R, KC N. Vaginal Leiomyoma: A Case Report. J Nepal Med Assoc. 2021;59(237):504-5.

Egbe TO, Kobenge FM, Metogo JAM, Manka’a WE, Tolefac PN, Belley-Priso E. Vaginal leiomyoma: medical imaging and diagnosis in a resource low tertiary hospital: case report. BMC Women Health. 2020;20:12.

Liu Y, Wang X, He Y. GnRH analogue followed by surgery in treatment of vaginal leiomyoma-a case report. Medicine. 2021;100(8):e24911.

Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, et al. The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer. 2013; 108(3):727-34.

Rajshekar SK, Guruprasad B, Shakunthala P, Rathod P, Devi U, Bafna U. Malignant mixed Mullerian tumour of the uterus. Cancer Med Sci. 2013;7:302.